ZA985142B - Captopril retard. - Google Patents
Captopril retard.Info
- Publication number
- ZA985142B ZA985142B ZA9805142A ZA985142A ZA985142B ZA 985142 B ZA985142 B ZA 985142B ZA 9805142 A ZA9805142 A ZA 9805142A ZA 985142 A ZA985142 A ZA 985142A ZA 985142 B ZA985142 B ZA 985142B
- Authority
- ZA
- South Africa
- Prior art keywords
- active ingredient
- optional excipients
- captopril
- retard
- pellet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19724696A DE19724696A1 (de) | 1997-06-12 | 1997-06-12 | Pharmazeutische Zubereitung mit drei Pelletarten |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA985142B true ZA985142B (en) | 2000-01-12 |
Family
ID=7832182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9805142A ZA985142B (en) | 1997-06-12 | 1998-06-12 | Captopril retard. |
Country Status (19)
Country | Link |
---|---|
US (1) | US6267990B1 (fr) |
EP (1) | EP0994696B1 (fr) |
JP (1) | JP2002504108A (fr) |
CN (1) | CN1260714A (fr) |
AT (1) | ATE259637T1 (fr) |
AU (1) | AU736357B2 (fr) |
CA (1) | CA2295013A1 (fr) |
DE (2) | DE19724696A1 (fr) |
DK (1) | DK0994696T3 (fr) |
ES (1) | ES2216296T3 (fr) |
HU (1) | HUP0002719A3 (fr) |
IL (1) | IL133442A0 (fr) |
NO (1) | NO996049L (fr) |
NZ (1) | NZ501726A (fr) |
PL (1) | PL192648B1 (fr) |
SK (1) | SK169999A3 (fr) |
TR (1) | TR199903069T2 (fr) |
WO (1) | WO1998056355A1 (fr) |
ZA (1) | ZA985142B (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4446463B2 (ja) * | 2000-10-16 | 2010-04-07 | 第一三共株式会社 | 口腔内速崩壊性医薬組成物およびその製造方法 |
FR2818550B1 (fr) * | 2000-12-26 | 2003-02-07 | Servier Lab | Composition pharmaceutique solide thermoformable pour la liberation controle de perindopril |
EP1499300B1 (fr) * | 2002-04-29 | 2009-03-18 | Supernus Pharmaceuticals, Inc. | Preparations pharmaceutiques aux caracteristiques biologiques de liberation ameliorees |
FR2841140B1 (fr) * | 2002-06-24 | 2004-10-01 | Servier Lab | Microcapsules pour la liberation retardee et controlee du perindopril |
AU2003244840C1 (en) * | 2002-07-05 | 2010-03-04 | Temrel Limited | Controlled release composition |
DK2210605T3 (en) | 2003-11-04 | 2017-05-22 | Tcd Royalty Sub Llc | Daily single dose doses of trospium. |
JP4771956B2 (ja) | 2003-11-04 | 2011-09-14 | スパーナス ファーマシューティカルズ インコーポレイテッド | バイオアベイラビリティーエンハンサを含む第四級アンモニウム化合物の組成物 |
US20050203168A1 (en) * | 2004-03-11 | 2005-09-15 | The Regents Of The University Of Michigan | Angiotensin converting enzyme inhibitor use for treatment and prevention of gastrointestinal disorders |
PL1750862T3 (pl) | 2004-06-04 | 2011-06-30 | Teva Pharma | Kompozycja farmaceutyczna zawierająca irbesartan |
KR100593795B1 (ko) | 2004-10-12 | 2006-06-30 | 대원제약주식회사 | 안정성이 개선된 라미프릴을 포함하는 경구투여용 제제 |
US8080579B2 (en) * | 2005-10-03 | 2011-12-20 | The Regents Of The University Of Michigan | Compositions and methods for treatment of inflammatory bowel disease |
US7731604B2 (en) * | 2006-10-31 | 2010-06-08 | Taylor Made Golf Company, Inc. | Golf club iron head |
MX2011000909A (es) * | 2008-07-30 | 2011-02-23 | Panacea Biotec Ltd | Composiciones de ramipril de liberacion modificada y usos de las mismas. |
RU2017106028A (ru) | 2014-09-19 | 2018-10-22 | Дзе Проктер Энд Гэмбл Компани | Лекарственная форма фенилэфрина с пульсирующим высвобождением |
US10278930B2 (en) | 2017-03-16 | 2019-05-07 | The Procter & Gamble Company | Method for relieving sinus congestion |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2836447A1 (de) * | 1978-08-19 | 1980-02-28 | Boehringer Sohn Ingelheim | Neue bunitrolol-retardform |
US4728512A (en) * | 1985-05-06 | 1988-03-01 | American Home Products Corporation | Formulations providing three distinct releases |
AU591248B2 (en) * | 1986-03-27 | 1989-11-30 | Kinaform Technology, Inc. | Sustained-release pharaceutical preparation |
US5158777A (en) * | 1990-02-16 | 1992-10-27 | E. R. Squibb & Sons, Inc. | Captopril formulation providing increased duration of activity |
US5326570A (en) * | 1991-07-23 | 1994-07-05 | Pharmavene, Inc. | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
US5876754A (en) * | 1992-01-17 | 1999-03-02 | Alfatec-Pharma Gmbh | Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies |
DE4431832A1 (de) * | 1994-09-07 | 1996-03-14 | Cordes Guenter Dr | Arzneimittelzubereitung für ACE-Hemmer |
DE19511131A1 (de) * | 1995-03-27 | 1996-10-02 | Basf Ag | Mechanisch stabile feste Wirkstoffzubereitungsformen |
-
1997
- 1997-06-12 DE DE19724696A patent/DE19724696A1/de not_active Ceased
-
1998
- 1998-06-12 ES ES98933605T patent/ES2216296T3/es not_active Expired - Lifetime
- 1998-06-12 AU AU83368/98A patent/AU736357B2/en not_active Ceased
- 1998-06-12 DK DK98933605T patent/DK0994696T3/da active
- 1998-06-12 CN CN98806157A patent/CN1260714A/zh active Pending
- 1998-06-12 CA CA002295013A patent/CA2295013A1/fr not_active Abandoned
- 1998-06-12 HU HU0002719A patent/HUP0002719A3/hu unknown
- 1998-06-12 JP JP50162599A patent/JP2002504108A/ja active Pending
- 1998-06-12 IL IL13344298A patent/IL133442A0/xx unknown
- 1998-06-12 AT AT98933605T patent/ATE259637T1/de not_active IP Right Cessation
- 1998-06-12 EP EP98933605A patent/EP0994696B1/fr not_active Expired - Lifetime
- 1998-06-12 NZ NZ501726A patent/NZ501726A/en unknown
- 1998-06-12 ZA ZA9805142A patent/ZA985142B/xx unknown
- 1998-06-12 DE DE59810803T patent/DE59810803D1/de not_active Expired - Fee Related
- 1998-06-12 WO PCT/EP1998/003536 patent/WO1998056355A1/fr active IP Right Grant
- 1998-06-12 SK SK1699-99A patent/SK169999A3/sk unknown
- 1998-06-12 TR TR1999/03069T patent/TR199903069T2/xx unknown
- 1998-06-12 PL PL337279A patent/PL192648B1/pl unknown
-
1999
- 1999-12-08 NO NO996049A patent/NO996049L/no not_active Application Discontinuation
- 1999-12-13 US US09/460,055 patent/US6267990B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
PL337279A1 (en) | 2000-08-14 |
CA2295013A1 (fr) | 1998-12-17 |
SK169999A3 (en) | 2000-07-11 |
WO1998056355A1 (fr) | 1998-12-17 |
TR199903069T2 (xx) | 2000-05-22 |
DE19724696A1 (de) | 1998-12-24 |
ATE259637T1 (de) | 2004-03-15 |
HUP0002719A2 (hu) | 2000-12-28 |
JP2002504108A (ja) | 2002-02-05 |
US6267990B1 (en) | 2001-07-31 |
AU8336898A (en) | 1998-12-30 |
EP0994696B1 (fr) | 2004-02-18 |
AU736357B2 (en) | 2001-07-26 |
EP0994696A1 (fr) | 2000-04-26 |
NZ501726A (en) | 2001-09-28 |
NO996049D0 (no) | 1999-12-08 |
DK0994696T3 (da) | 2004-06-01 |
NO996049L (no) | 2000-02-07 |
CN1260714A (zh) | 2000-07-19 |
HUP0002719A3 (en) | 2001-04-28 |
IL133442A0 (en) | 2001-04-30 |
DE59810803D1 (de) | 2004-03-25 |
PL192648B1 (pl) | 2006-11-30 |
ES2216296T3 (es) | 2004-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA985142B (en) | Captopril retard. | |
NZ502280A (en) | Combination therapy comprising atorvastatin and an antihypertensive agent | |
CA2199778A1 (fr) | Formulation de venlafaxine a liberation prolongee | |
CA2171275A1 (fr) | Derives du stilbene et compositions pharmaceutiques qui en renferment | |
GEP20012388B (en) | Metalloproteinase Inhibitors, Pharmaceutical Compositions on Their Base, Use and Methods for Obtaining and Intermediates | |
HUP0301972A2 (hu) | Fentanilszerű szerkezetű opioidot és ketamint tartalmazó hatóanyag-kombináció és ezt tartalmazó gyógyszerkészítmény | |
GEP20002211B (en) | Taxoids, Preparation Thereof, Pharmaceutical Compositions Containing Same | |
CA2411754A1 (fr) | Acide 4-¬(4-chloro-2-hydroxybenzoyl)amino|butanoique et compositions d'administration d'agents actifs | |
CA2238553A1 (fr) | Composition abaissant le taux de cholesterol | |
ATE424810T1 (de) | Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung | |
ATE260658T1 (de) | Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen | |
ZA98214B (en) | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1. | |
PL309282A1 (en) | Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant | |
WO1995001168A3 (fr) | Preparations pharmaceutiques avec un principe actif contenant des groupes amidine modifies | |
WO2000039083A3 (fr) | Composes pyrazole et utilisation de tels composes | |
TW275585B (fr) | ||
CA2173147A1 (fr) | Agent anti-obesite | |
WO2003045327A3 (fr) | Preparations de cachet d'efavirenz possedant des caracteristiques biopharmaceutiques uniques | |
SI1105105T1 (sl) | Oralna dajalna oblika za piridin-2-ilmetilsulfinil-1J-benzimidazole | |
EP0610519A4 (en) | Anti-hiv drug. | |
GB9515279D0 (en) | Improved therapeutic agents | |
AU3580995A (en) | Derivatives of carbohydrates and compositions containing them | |
MY115795A (en) | Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them | |
WO1999027921A3 (fr) | Compositions et procedes de modulation de l'activite du facteur de croissance des fibroblastes (fgf) | |
CA2288966A1 (fr) | Medicaments de prevention ou de traitement de la recto-colite hemorragique et/ou de la maladie de crohn |